We are live on ! Find out more
BNTX icon

BioNTech

92.75 USD
+1.15
1.26%
At close Updated Aug 18, 4:00 PM EDT
Pre-market
After hours
92.75
0.00
0%
1 day
1.26%
5 days
0.53%
1 month
0.64%
3 months
4.39%
6 months
-14.08%
Year to date
-4.07%
1 year
-17.59%
5 years
-74.52%
10 years
551.33%
 

About: BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Employees: 7,807

0
Funds holding %
of 8,250 funds
0
Positive news %
of 12 articles
Price charts implemented using Lightweight Charts™